[{"command":"settings","settings":{"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJxdyl0KhDAMRtEN1XZJ8mliDaQ1pD-z_YFhUPDxHi5v07pSkjqFP4H_WZgEixRkflmb-RaDIzvsXMpF0HWHU_ht6RDt7HGHdblquM-WyIdB4yNxVBubSjuZvnheN14","theme":"ebvptld","theme_token":null},"ajaxTrustedUrl":[],"user":{"uid":0,"permissionsHash":"4867837929d82f46a0b8d631cb1b853ab572e5989466da9ff30f538d13a4af8e"}},"merge":true},{"command":"add_css","data":[{"rel":"stylesheet","media":"all","href":"\/sites\/default\/files\/css\/css_zFE0GntIr5sJtoaw0onuR1rz-A25LT_DlBnsJ-mCx8I.css?delta=0\u0026language=en\u0026theme=ebvptld\u0026include=eJxFykEOgCAMBMAPITzJLLRKkwJNAd_vTa-T4fzYUkoGx-2werRB0LPAKTQmQbpEF3sssCWjh2_ORL4NGn-Ju9vOKrMyvTgpIzs"},{"rel":"stylesheet","media":"all","href":"\/sites\/default\/files\/css\/css_rp-nJs0EOjtUdAxu7hbmuIO3NIwEYbwhfB4JNT82dPg.css?delta=1\u0026language=en\u0026theme=ebvptld\u0026include=eJxFykEOgCAMBMAPITzJLLRKkwJNAd_vTa-T4fzYUkoGx-2werRB0LPAKTQmQbpEF3sssCWjh2_ORL4NGn-Ju9vOKrMyvTgpIzs"}]},{"command":"add_js","selector":"body","data":[{"src":"\/sites\/default\/files\/js\/js_fgI_F9T9iHdlscNdB1Tqblhfn81ETkj65lf7riv4k8o.js?scope=footer\u0026delta=0\u0026language=en\u0026theme=ebvptld\u0026include=eJxLzi9K1U8pKi1IzNFLyUzMyU_XS8xKrNBJTSorKMlJ0c_MK8tMLYdzyyuLM8sr0wE6xBUe"}]},{"command":"openDialog","selector":"#drupal-modal","settings":null,"data":"\n  \u003Cdiv id=\u0022p205\u0022 class=\u0022js-inview paragraph paragraph--type--modal-card paragraph--view-mode--teaser modal wysiwyg\u0022\u003E\n         \n  \u003Ch3\u003E\u003Cstrong\u003EPTLD-1 ST STUDY\u003Csup\u003E12\u003C\/sup\u003E\u003C\/strong\u003E\u003C\/h3\u003E\n\u003Cp\u003E\u003Cspan class=\u0022regular\u0022\u003E\u003Cstrong\u003ESequential treatment: rituximab \u0026gt; CHOP\u003C\/strong\u003E\u003C\/span\u003E\u003Cbr\u003E\u003Cspan class=\u0022regular\u0022\u003EIn a Phase 2 study of patients with CD20+ PTLD refractory to initial RIS, 90% (53\/59) achieved complete or partial response after four weekly doses of rituximab followed by four 21-day cycles of CHOP.\u003C\/span\u003E\u003C\/p\u003E\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\n\u003Cdiv class=\u0022flex\u0022\u003E\n\u003Cdiv class=\u0022study1Card\u0022\u003E\n\u003Ch4 class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022purple-light\u0022\u003E\u003Cstrong\u003ERESPONSE\u003C\/strong\u003E\u003C\/span\u003E\u003C\/h4\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Csvg version=\u00221.1\u0022 id=\u0022Layer_1\u0022 x=\u00220px\u0022 y=\u00220px\u0022 viewBox=\u00220 0 130.6 130.6\u0022 style=\u0022enable-background:new 0 0 130.6 130.6;\u0022 xml:space=\u0022preserve\u0022 xmlns:xlink=\u0022http:\/\/www.w3.org\/1999\/xlink\u0022 xmlns:graph=\u0022http:\/\/ns.adobe.com\/Graphs\/1.0\/\u0022 xmlns:i=\u0022http:\/\/ns.adobe.com\/AdobeIllustrator\/10.0\/\u0022 xmlns:x=\u0022http:\/\/ns.adobe.com\/Extensibility\/1.0\/\u0022\u003E\n\u003Cstyle type=\u0022text\/css\u0022\u003E\n\t.Drop_x0020_Shadow{fill:none;}\n\t.Outer_x0020_Glow_x0020_5_x0020_pt{fill:none;}\n\t.Blue_x0020_Neon{fill:none;stroke:#8AACDA;stroke-width:7;stroke-linecap:round;stroke-linejoin:round;}\n\t.Chrome_x0020_Highlight{fill:url(#SVGID_1_);stroke:#FFFFFF;stroke-width:0.3629;stroke-miterlimit:1;}\n\t.Jive_GS{fill:#FFDD00;}\n\t.Alyssa_GS{fill:#A6D0E4;}\n\t.st0_study-1-90{fill:#2A2360;}\n\t.st1_study-1-90{opacity:0.2;}\n\t.st2_study-1-90{fill:#2E3098;}\n\t.st3_study-1-90{fill:url(#SVGID_00000114037889173097442240000013630668251789583787_);}\n\u003C\/style\u003E\n\u003Cmetadata\u003E\n\n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                           \n\n\t\u003C\/metadata\u003E\n\u003ClinearGradient id=\u0022SVGID_1_\u0022 gradientUnits=\u0022userSpaceOnUse\u0022 x1=\u0022-634.7451\u0022 y1=\u0022-384.8758\u0022 x2=\u0022-634.7451\u0022 y2=\u0022-385.8758\u0022\u003E\n\t\u003Cstop offset=\u00220\u0022 style=\u0022stop-color:#656565\u0022 \/\u003E\n\t\u003Cstop offset=\u00220.618\u0022 style=\u0022stop-color:#1B1B1B\u0022 \/\u003E\n\t\u003Cstop offset=\u00220.6292\u0022 style=\u0022stop-color:#545454\u0022 \/\u003E\n\t\u003Cstop offset=\u00220.9831\u0022 style=\u0022stop-color:#3E3E3E\u0022 \/\u003E\n\u003C\/linearGradient\u003E\n\u003Cg\u003E\n\t\u003Cpath class=\u0022st0_study-1-90\u0022 d=\u0022M55.8,65.4l-4.8,8h-3.4l3.3-5.6l0,0c-0.1,0-0.3,0-0.4,0c-1.6,0-2.9-0.5-4.1-1.6c-1.1-1-1.7-2.3-1.7-3.9   c0-1.6,0.6-2.9,1.7-4c1.1-1,2.6-1.5,4.2-1.5s3.1,0.5,4.2,1.5c1.1,1,1.7,2.3,1.7,4C56.6,63.6,56.3,64.6,55.8,65.4z M47.9,62.4   c0,0.7,0.3,1.4,0.8,1.9c0.5,0.5,1.2,0.8,1.9,0.8s1.4-0.3,1.9-0.8s0.8-1.2,0.8-1.9c0-0.8-0.3-1.4-0.8-2s-1.2-0.8-1.9-0.8   s-1.4,0.3-1.9,0.8C48.2,60.9,47.9,61.6,47.9,62.4z\u0022 \/\u003E\n\t\u003Cpath class=\u0022st0_study-1-90\u0022 d=\u0022M70.4,62.6v5.5c0,1.6-0.6,2.9-1.8,4c-1.2,1.1-2.6,1.7-4.3,1.7s-3.1-0.6-4.3-1.7s-1.8-2.4-1.8-4v-5.5   c0-1.6,0.6-2.9,1.8-4s2.6-1.7,4.3-1.7s3.1,0.6,4.3,1.7C69.8,59.7,70.4,61,70.4,62.6z M67.4,68.3v-5.9c0-0.8-0.3-1.4-0.9-2   c-0.6-0.5-1.3-0.8-2.1-0.8c-0.9,0-1.6,0.3-2.1,0.8c-0.6,0.5-0.8,1.2-0.8,1.9v5.9c0,0.8,0.3,1.4,0.8,1.9c0.6,0.5,1.3,0.8,2.1,0.8   c0.8,0,1.6-0.3,2.1-0.8C67.1,69.7,67.4,69.1,67.4,68.3z\u0022 \/\u003E\n\t\u003Cpath class=\u0022st0_study-1-90\u0022 d=\u0022M79.6,58.1c0.8,0.8,1.3,1.8,1.3,2.9c0,1.1-0.4,2.1-1.3,2.9c-0.8,0.8-1.8,1.2-3,1.2s-2.1-0.4-3-1.2   c-0.8-0.8-1.3-1.8-1.3-2.9c0-1.1,0.4-2.1,1.3-2.9s1.8-1.2,3-1.2S78.8,57.3,79.6,58.1z M78,62.3c0.4-0.4,0.6-0.8,0.6-1.3   c0-0.5-0.2-1-0.6-1.3c-0.4-0.4-0.8-0.6-1.3-0.6s-0.9,0.2-1.3,0.6C75,60,74.8,60.5,74.8,61c0,0.5,0.2,1,0.6,1.3   c0.4,0.4,0.8,0.6,1.3,0.6S77.6,62.7,78,62.3z M76.2,73.8L75,73l10.9-16.1l1.2,0.8L76.2,73.8z M88.4,66.7c0.8,0.8,1.3,1.8,1.3,2.9   s-0.4,2.1-1.3,2.9c-0.8,0.8-1.8,1.2-3,1.2c-1.2,0-2.1-0.4-3-1.2c-0.8-0.8-1.3-1.8-1.3-2.9s0.4-2.1,1.3-2.9s1.8-1.2,3-1.2   C86.6,65.5,87.6,65.9,88.4,66.7z M86.8,71c0.4-0.4,0.6-0.8,0.6-1.3c0-0.5-0.2-1-0.6-1.3c-0.4-0.4-0.8-0.6-1.3-0.6   c-0.5,0-0.9,0.2-1.3,0.6c-0.4,0.4-0.6,0.8-0.6,1.3c0,0.5,0.2,1,0.6,1.3s0.8,0.6,1.3,0.6C85.9,71.5,86.4,71.3,86.8,71z\u0022 \/\u003E\n\u003C\/g\u003E\n\u003Cg class=\u0022st1_study-1-90\u0022\u003E\n\t\u003Cg\u003E\n\t\t\u003Cpath class=\u0022st2_study-1-90\u0022 d=\u0022M34.6,23l-7.6-10.5C38.5,4.1,51,0,65.3,0v13C53.7,13,43.9,16.2,34.6,23z\u0022 \/\u003E\n\t\u003C\/g\u003E\n\u003C\/g\u003E\n\u003Cg\u003E\n\t\u003Cg\u003E\n\t\t\n\t\t\t\u003ClinearGradient id=\u0022SVGID_00000029761652600525753240000017942504158093561508_\u0022 gradientUnits=\u0022userSpaceOnUse\u0022 x1=\u002220.2683\u0022 y1=\u00229.4861\u0022 x2=\u002269.2444\u0022 y2=\u002270.1889\u0022\u003E\n\t\t\t\u003Cstop offset=\u00220\u0022 style=\u0022stop-color:#AB0083\u0022 \/\u003E\n\t\t\t\u003Cstop offset=\u00221\u0022 style=\u0022stop-color:#691F84\u0022 \/\u003E\n\t\t\u003C\/linearGradient\u003E\n\t\t\u003Cpath style=\u0022fill:url(#SVGID_00000029761652600525753240000017942504158093561508_);\u0022 d=\u0022M65.3,130.6c-36,0-65.3-29.3-65.3-65.3    c0-21.5,9.6-40.2,26.9-52.8c2.9-2.1,7-1.5,9.1,1.4c2.1,2.9,1.5,7-1.4,9.1C20.5,33.2,13,47.9,13,65.3c0,28.8,23.5,52.3,52.3,52.3    c28.8,0,52.3-23.5,52.3-52.3c0-28.8-23.5-52.3-52.3-52.3c-3.6,0-6.5-2.9-6.5-6.5S61.7,0,65.3,0c36,0,65.3,29.3,65.3,65.3    C130.6,101.3,101.3,130.6,65.3,130.6z\u0022 \/\u003E\n\t\u003C\/g\u003E\n\u003C\/g\u003E\n\u003C\/svg\u003E\n\n\n\u003C\/div\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003EORR after sequential treatment\u003C\/strong\u003E\u0026nbsp;\u003C\/span\u003E\u003Cbr\u003E\u003Cspan class=\u0022smallish\u0022\u003E(95% CI, 79\u201396%; n=59)\u003C\/span\u003E\u003C\/p\u003E\n\u003Ch4 class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022purple-light\u0022\u003E\u003Cstrong\u003EVS\u003C\/strong\u003E\u003C\/span\u003E\u003C\/h4\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-60%25.png?itok=WoGvL4AC\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002260 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003EORR after rituximab\u003C\/strong\u003E\u003C\/span\u003E\u003Cbr\u003E\u003Cspan class=\u0022smallish\u0022\u003E(95% CI, 48\u201371%; n=70)\u003C\/span\u003E\u003C\/p\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022study1Card\u0022\u003E\n\u003Ch4 class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022purple-light\u0022\u003E\u003Cstrong\u003ESURVIVAL\u003C\/strong\u003E\u003C\/span\u003E\u003C\/h4\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cstrong\u003E6.6 years\u003C\/strong\u003E\u0026nbsp;\u003Cbr\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003Emedian OS\u003C\/strong\u003E (ITT, N=70)\u003C\/span\u003E\u003C\/p\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-61%25.png?itok=xClzlpbp\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002261 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-55%25.png?itok=ZUWKPgh-\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002255 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EMedian follow-up 5.1 years. In the per protocol analysis (N=63), median OS was not reached; OS at 3 and 5 years was 65% and 57%, respectively.\u003C\/span\u003E\u003C\/p\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022study1Card\u0022\u003E\n\u003Ch4 class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022purple-light\u0022\u003E\u003Cstrong\u003ETIME TO PROGRESSION\u003C\/strong\u003E\u003C\/span\u003E\u003C\/h4\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003E77.4 months\u003C\/strong\u003E\u0026nbsp;\u003C\/span\u003E\u003Cbr\u003E\u003Cspan class=\u0022smallish\u0022\u003Emedian TTP\u003C\/span\u003E\u003C\/p\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-69%25.png?itok=ikTQft1G\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002269 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-66%25.png?itok=3fglq_sg\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002266 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EMedian TTP per protocol (N=63) was not reached (\u0026gt;86.9 months)\u003C\/span\u003E\u003C\/p\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022study1Card\u0022\u003E\n\u003Ch4 class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022purple-light\u0022\u003E\u003Cstrong\u003EMORTALITY\u003C\/strong\u003E\u003C\/span\u003E\u003C\/h4\u003E\n\u003Cdiv\u003E\n  \n  \n    \u003Cimg src=\u0022\/sites\/default\/files\/styles\/rte\/public\/2026-02\/study1-10.6%25.png?itok=9Gu5luYy\u0022 width=\u0022400\u0022 height=\u0022400\u0022 alt=\u002210.6 %\u0022 loading=\u0022lazy\u0022\u003E\n\n\n\n\n\u003C\/div\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022smallish\u0022\u003E(7\/66)\u000bCHOP-associated mortality\u003Cstrong\u003E\u0026nbsp;\u003C\/strong\u003E\u003C\/span\u003E\u003C\/p\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u0026nbsp;\u003C\/p\u003E\n\u003Cp class=\u0022text-align-center\u0022\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003E5 out of 7 \u003C\/strong\u003ECHOP-related \u0003deaths (71%) occurred \u0026nbsp;in\u003Cstrong\u003E\u0026nbsp;non-responders\u0026nbsp;\u003C\/strong\u003Eto rituximab\u003C\/span\u003E\u003C\/p\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022row\u0022 style=\u0022margin:0 -1.2rem;\u0022\u003E\n\u003Cdiv class=\u0022col-md-12\u0022 style=\u0022padding:1.2rem;\u0022\u003E\n\u003Cp\u003E\u003Cbr\u003E\u003Cspan class=\u0022smallish\u0022\u003E\u003Cstrong\u003EStudy design\u003C\/strong\u003E\u003C\/span\u003E\u003C\/p\u003E\n\u003Cul\u003E\n\u003Cli data-list-item-id=\u0022e4b20c7613dd02084b21054146decb0c5\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EInternational, multicentre, open-label phase 2 trial\u0026nbsp;\u003C\/span\u003E\u003C\/li\u003E\n\u003Cli data-list-item-id=\u0022e0e832fb7f0ca5253f4a20a563d1a512e\u0022\u003E\u003Cspan class=\u0022small\u0022\u003E70 treatment-naive adult SOT recipients with CD20-positive PTLD unresponsive to RIS\u003C\/span\u003E\u003C\/li\u003E\n\u003Cli data-list-item-id=\u0022eb282c856a30dea1e694ed60a407f2d3e\u0022\u003E\u003Cspan class=\u0022small\u0022\u003ETreatment regimen: four courses of rituximab once a week followed by 4 weeks without treatment and four cycles of CHOP every 3 weeks\u0026nbsp;\u003C\/span\u003E\u003C\/li\u003E\n\u003Cli data-list-item-id=\u0022e80434073f42704565ff19c87f25634a3\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EPrimary endpoint: treatment efficacy, assessed by response rates in patients who completed rituximab and CHOP per protocol, and response duration in those who completed all planned therapy and responded\u003C\/span\u003E\u003C\/li\u003E\n\u003C\/ul\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022col-md-12\u0022 style=\u0022padding:1.2rem;\u0022\u003E\n\u003Cp\u003E\u003Cbr\u003E\u003Cspan class=\u0022regular smallish\u0022\u003E\u003Cstrong\u003EAdverse events\u003C\/strong\u003E\u003C\/span\u003E\u003C\/p\u003E\n\u003Cul\u003E\n\u003Cli data-list-item-id=\u0022eedcee632bf219999215abab82341587f\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EGrade 3\/4 infections in 41% of patients\u0026nbsp;\u003C\/span\u003E\u003C\/li\u003E\n\u003Cli data-list-item-id=\u0022ea53a9bc56f9e9d3d4f8a1a52ae4b641a\u0022\u003E\u003Cspan class=\u0022small\u0022\u003EGrade 3\/4 leukopenia in 68% of patients\u0026nbsp;\u003C\/span\u003E\u003C\/li\u003E\n\u003Cli data-list-item-id=\u0022e49b1d65f323d192e4997d9c23fe6284f\u0022\u003E\u003Cspan class=\u0022small\u0022\u003E11% experienced CHOP-associated treatment-related mortality\u003C\/span\u003E\u003C\/li\u003E\n\u003C\/ul\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\n\n\n      \u003C\/div\u003E\n","dialogOptions":{"width":"60%","modal":true,"title":""}}]